Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs

P. A. Jacobson, D. Schladt, W. S. Oetting, R. Leduc, W. Guan, A. J. Matas, A. Israni

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Abstract

The number of older adults undergoing kidney transplantation has increased, yet little is known about calcineurin inhibitor (CNI) metabolism in this group. We studied CNI troughs and doses to determine if there were age-related differences in metabolism and dose requirements. We studied 348 young (18-34 years), 1831 middle (35-64 years) and 374 older (65-84 years) adult kidney transplant recipients enrolled in a seven-center prospective study. Troughs were obtained from each patient 2×/week in weeks 1-8 and 2×/month in months 3-6. A multivariable linear-mixed model examined the effect of age on log dose and weight normalized troughs. Older recipients had higher normalized tacrolimus troughs than middle or young age adults despite receiving doses a median of 1-2 mg/day lower. Age and CYP3A5*1 genotype had the largest effect on tacrolimus troughs. Older recipients also had higher normalized cyclosporine troughs than middle or young adults despite receiving median doses 100 mg/day lower. After normalization for dose and weight, CNI troughs were more than 50% higher in older adults than young adults. These data support age-related changes in CNI metabolism. Further studies are needed to determine optimal dosing of CNIs in the elderly.

Original languageEnglish (US)
Pages (from-to)3326-3336
Number of pages11
JournalAmerican Journal of Transplantation
Volume12
Issue number12
DOIs
StatePublished - Dec 2012
Externally publishedYes

Keywords

  • Calcineurin inhibitor
  • cyclosporine
  • elderly
  • kidney transplant
  • pharmacokinetics
  • tacrolimus
  • trough

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs'. Together they form a unique fingerprint.

Cite this